Tower Research Capital (TRC)’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,481
| Closed | -$4K | – | 6654 |
|
|
2023
Q1 | $4K | Sell |
1,481
-5,208
| -78% | -$14.1K | ﹤0.01% | 5158 |
|
|
2022
Q4 | $27K | Buy |
6,689
+6,313
| +1,679% | +$25.5K | ﹤0.01% | 2866 |
|
|
2022
Q3 | $3K | Sell |
376
-54
| -13% | -$431 | ﹤0.01% | 5493 |
|
|
2022
Q2 | $5K | Buy |
430
+325
| +310% | +$3.78K | ﹤0.01% | 5151 |
|
|
2022
Q1 | $2K | Buy |
+105
| New | +$2K | ﹤0.01% | 5703 |
|
|
2021
Q4 | – | Sell |
-166
| Closed | -$11K | – | 6885 |
|
|
2021
Q3 | $11K | Buy |
+166
| New | +$11K | ﹤0.01% | 4286 |
|
|
2021
Q2 | – | Sell |
-906
| Closed | -$59K | – | 6086 |
|
|
2021
Q1 | $59K | Buy |
906
+25
| +3% | +$1.63K | ﹤0.01% | 2987 |
|
|
2020
Q4 | $51K | Buy |
+881
| New | +$51K | ﹤0.01% | 3117 |
|
|
2019
Q4 | – | Sell |
-63
| Closed | -$8K | – | 4653 |
|
|
2019
Q3 | $8K | Buy |
63
+19
| +43% | +$2.41K | ﹤0.01% | 3105 |
|
|
2019
Q2 | $13K | Buy |
+44
| New | +$13K | ﹤0.01% | 2430 |
|
|
2019
Q1 | – | Sell |
-89
| Closed | -$40K | – | 4488 |
|
|
2018
Q4 | $40K | Buy |
89
+78
| +709% | +$35.1K | ﹤0.01% | 1440 |
|
|
2018
Q3 | $10K | Buy |
+11
| New | +$10K | ﹤0.01% | 2792 |
|
|
2017
Q2 | – | Sell |
-3
| Closed | -$4K | – | 3780 |
|
|
2017
Q1 | $4K | Buy |
+3
| New | +$4K | ﹤0.01% | 2379 |
|
|
2016
Q4 | – | Sell |
-2
| Closed | -$1K | – | 4580 |
|
|
2016
Q3 | $1K | Sell |
2
-1
| -33% | -$500 | ﹤0.01% | 3421 |
|
|
2016
Q2 | $2K | Buy |
3
+2
| +200% | +$1.33K | ﹤0.01% | 4004 |
|
|
2016
Q1 | $1K | Sell |
1
-1
| -50% | -$1K | ﹤0.01% | 3855 |
|
|
2015
Q4 | $1K | Hold |
2
| – | – | ﹤0.01% | 4218 |
|
|
2015
Q3 | $3K | Buy |
+2
| New | +$3K | ﹤0.01% | 3200 |
|